The clinical significance of these findings was evidenced by the positive correlations of PFKP Y64 phosphorylation with HIF-1α expression, β-catenin S552 phosphorylation, and VEGF expression in human GBM specimens. The gene discussed is HIF1A; the disease is glioblastoma.